Linnaeus Therapeutics
Developer of molecular therapeutics designed to treat cancer and skin pigmentation disorders. The company's therapeutics utilize small-molecule agents to increase or decrease the amount of melanin pig...
Valuation
$0
Share Price
N/A
Total Raised
$30.9M
Last Round
N/A